SVETLANA MIRONENKO: Open Payments
NPI 1730561697 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 26 payments from 7 companies in 2025. Trend: 2023 $1,252 · 2024 $993 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $364 |
| ABBVIE INC. | 16 | $243 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Ardelyx, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: JARDIANCE, CREON, CAMZYOS, RINVOQ, XIFAXAN, IBSRELA, SKYRIZI, LINZESS.
Industry payments across NY — which companies pay providers there.
